Literature DB >> 33888565

The roles and regulation of MDM2 and MDMX: it is not just about p53.

Alyssa M Klein1, Rafaela Muniz de Queiroz2, Divya Venkatesh2, Carol Prives2.   

Abstract

Most well studied as proteins that restrain the p53 tumor suppressor protein, MDM2 and MDMX have rich lives outside of their relationship to p53. There is much to learn about how these two proteins are regulated and how they can function in cells that lack p53. Regulation of MDM2 and MDMX, which takes place at the level of transcription, post-transcription, and protein modification, can be very intricate and is context-dependent. Equally complex are the myriad roles that these two proteins play in cells that lack wild-type p53; while many of these independent outcomes are consistent with oncogenic transformation, in some settings their functions could also be tumor suppressive. Since numerous small molecules that affect MDM2 and MDMX have been developed for therapeutic outcomes, most if not all designed to prevent their restraint of p53, it will be essential to understand how these diverse molecules might affect the p53-independent activities of MDM2 and MDMX.
© 2021 Klein et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  MDM2; MDM2 and MDMX inhibitors; MDMX; cancer; p53; pathologies; roles; upstream regulation

Year:  2021        PMID: 33888565     DOI: 10.1101/gad.347872.120

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  14 in total

Review 1.  Japonicone A and related dimeric sesquiterpene lactones: molecular targets and mechanisms of anticancer activity.

Authors:  Christian Bailly; Gérard Vergoten
Journal:  Inflamm Res       Date:  2022-01-16       Impact factor: 4.575

2.  MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.

Authors:  Alyssa M Klein; Lynn Biderman; David Tong; Bita Alaghebandan; Sakina A Plumber; Helen S Mueller; Anne van Vlimmeren; Chen Katz; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-02       Impact factor: 11.205

3.  Structural studies of antitumor compounds that target the RING domain of MDM2.

Authors:  James Ross Terrell; Sijia Tang; Oluwafoyinsola Omobodunde Faniyi; In Ho Jeong; Jun Yin; Bhavitavya Nijampatnam; Sadanandan E Velu; Wei Wang; Ruiwen Zhang; Ming Luo
Journal:  Protein Sci       Date:  2022-08       Impact factor: 6.993

Review 4.  p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).

Authors:  Daniela Milani; Lorenzo Caruso; Enrico Zauli; Adi Mohammed Al Owaifeer; Paola Secchiero; Giorgio Zauli; Donato Gemmati; Veronica Tisato
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

Review 5.  Cell Death and the p53 Enigma During Mammalian Embryonic Development.

Authors:  Sonam Raj; Sushil K Jaiswal; Melvin L DePamphilis
Journal:  Stem Cells       Date:  2022-03-31       Impact factor: 5.845

6.  Identification and functional interpretation of miRNAs affected by rare CNVs in CAKUT.

Authors:  Kristina Mitrovic; Ivan Zivotic; Ivana Kolic; Ana Djordjevic; Jelena Zakula; Jelena Filipovic Trickovic; Maja Zivkovic; Aleksandra Stankovic; Ivan Jovanovic
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

7.  AURKB, in concert with REST, acts as an oxygen-sensitive epigenetic regulator of the hypoxic induction of MDM2.

Authors:  Iljin Kim; Sanga Choi; Seongkyeong Yoo; Mingyu Lee; Jong-Wan Park
Journal:  BMB Rep       Date:  2022-06       Impact factor: 5.041

Review 8.  Developmental Acquisition of p53 Functions.

Authors:  Sushil K Jaiswal; Sonam Raj; Melvin L DePamphilis
Journal:  Genes (Basel)       Date:  2021-10-23       Impact factor: 4.096

Review 9.  Targeting NRF2 to treat cancer.

Authors:  Jared Sivinski; Donna D Zhang; Eli Chapman
Journal:  Semin Cancer Biol       Date:  2021-06-05       Impact factor: 15.707

Review 10.  SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication.

Authors:  Lulzim Shkreta; Aurélie Delannoy; Anna Salvetti; Benoit Chabot
Journal:  RNA       Date:  2021-07-27       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.